COVID-19: Documentos de interés desde su inicio

Este es un espacio multidisciplinar dirigido a profesionales de la salud que luchan cada día contra el COVID-19.

Su objetivo es incorporar de forma regular publicaciones científicas, guías o recomendaciones que puedan ayudar al profesional a conocer mejor la enfermedad, su diagnóstico y su manejo terapéutico.

A pesar de hacer un filtrado previo, queremos poner de manifiesto que en la selección de artículos que incluimos probablemente no todos cuenten con el mismo nivel de calidad. No hay, ni habrá por ejemplo, publicaciones basadas en medicinas alternativas, pero es posible encontrar algunas publicaciones que estén realizadas con grupos pequeños de pacientes, circunstancia justificada por la presión del tiempo para salvar pacientes de compartir con los profesionales los pequeños avances de cada día.

Dejamos a criterio del profesional de la medicina la valoración de estas publicaciones.

CLASIFICACIÓN POR ÁREAS TEMÁTICAS

GUÍAS Y RECOMENDACIONES

Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 Mar 28. doi: 10.1007/s00134-020-06022-5. [Epub ahead of print]

Documentos técnicos para profesionales del Ministerio de Sanidad, Consumo y Bienestar Social

POSICIONAMIENTO Y RECOMENDACIONES SEMICYUC

Plan de Contingencia para los Servicios de Medicina Intensiva frente a la pandemia COVID-19.

Recomendaciones del GTEIS-SEMICYUC para el manejo inicial de la vía aérea en pacientes con sospecha de coronavirus.

Recomendaciones éticas para la toma de decisiones en la situación excepcional de crisis por pandemia COVID-19 en las unidades de cuidados intensivos (SEMICYUC).

Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. WHO/COVID-19/laboratory/2020.5

Montero Feijoo A, et al. Recomendaciones prácticas para el manejo perioperatorio del paciente con sospecha o infección grave por coronavirus SARS-CoV-2. Rev Esp Anestesiol Reanim. 2020. https://doi.org/10.1016/j.redar.2020.03.003.

Thomas-Rüddel D, Winning J, Dickmann P et al. Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020. Anaesthesist. 2020 Mar 24. doi: 10.1007/s00101-020-00760-3. [Epub ahead of print]

Barazzoni R et al. ESPEN expert statements and practical guidance for nutritional management of individuals with. SARS-CoV-2 infection, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2020.03.022

Recomendaciones SEUP por SARS-CoV-2 (cuadro clínico: COVID-19)

SARS-CoV-2

Sagripanti JL, Lytle CD. Estimated Inactivation of Coronaviruses by Solar Radiation With Special Reference to COVID-19. Photochem Photobiol. 2020;96(4):731-737. doi:10.1111/php.13293

Sportelli MC, Izzi M, Kukushkina EA, et al. Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?. Nanomaterials (Basel). 2020;10(4):E802. Published 2020 Apr 21. doi:10.3390/nano10040802

Dawood AA. Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future. New Microbes New Infect. 2020;35:100673. doi:10.1016/j.nmni.2020.100673 [published online ahead of print, 2020 Apr 4]

Srinivasan S, Cui H, Gao Z, Liu M, Lu S, Mkandawire W et al. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins. Viruses. 2020 Mar 25;12(4). pii: E360. doi: 10.3390/v12040360.

Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. doi: 10.12932/AP-200220-0772.

Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Robert F. Garry RF. The proximal origin of SARS-CoV-2. Nat Med (2020). https://doi.org/10.1038/s41591-020-0820-9.

EPIDEMIOLOGÍA

Ge H, Wang X, Yuan X, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011-1019. doi:10.1007/s10096-020-03874-z

Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A Systematic Review of COVID-19 Epidemiology Based on Current Evidence. J Clin Med. 2020 Mar 31;9(4). pii: E967. doi: 10.3390/jcm9040967.

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 Feb 26:102433.

CLÍNICA

Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X et al. Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes. Invest Radiol. 2020 Jun;55(6):332-339. doi: 10.1097/RLI.0000000000000674.

Feng Y, Ling Y, Bai TT, Xie Y, JHuang J, Li J et al. COVID-19 With Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388. doi: 10.1164/rccm.202002-0445OC.

Hajifathalian K, Mahadev S, Schwartz RE, Shah S, Sampath K, Schnoll-Sussman F et al. SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant. World J Gastroenterol 2020 April 14; 26(14): 1546-1553.

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020. doi: 10.1111/all.14238. [Epub ahead of print].

Vetter Pauline, Vu Diem Lan, L’Huillier Arnaud G, Schibler Manuel, Kaiser Laurent, Jacquerioz Frederique et al. Clinical features of covid-19. BMJ 2020; 369 :m1470

Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L et al. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020 Mar 31. doi: 10.1001/jamaophthalmol.2020.1291. [Epub ahead of print]

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506.

DIAGNÓSTICO

Zhang G, Nie S, Zhang Z, Zhang Z. Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19. J Infect Dis. 2020;jiaa229. doi:10.1093/infdis/jiaa229 [published online ahead of print, 2020 May 2]

Long C, Xu H, Shen Q, Zhang X, Fan B, Wang C et al. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol. 2020 Mar 25;126:108961. doi: 10.1016/j.ejrad.2020.108961. [Epub ahead of print]

Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. 2020 Mar 19. doi: 10.1007/s00330-020-06801-0. [Epub ahead of print]

Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020 Feb 26:200642. doi: 10.1148/radiol.2020200642. [Epub ahead of print]

Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020 Feb 21:200490.

TRATAMIENTO

Nadkarni GN, Lala A, Bagiella E, Chang HL, Moreno P, Pujadas E, et al. Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hospitalized with COVID-19: A Single Health System Study. J Am Coll Cardiol. 2020 Aug 26. Epublished DOI:10.1016/j.jacc.2020.08.041

Paranjpe I, Fuster V, Lala A, Russak A, Glicksberg BS, Levin MA, et al. Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19. J Am Coll Cardiol. 2020;76 (1) 122-124.

Jean SS, Lee PI, Hsueh PR. Treatment Options for COVID-19: The Reality and Challenges. J Microbiol Immunol Infect. 2020 Jun;53(3):436-443. doi: 10.1016/j.jmii.2020.03.034. Epub 2020 Apr 4.

Schijns V, Lavelle EC. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity. Eur J Immunol. 2020;50(7):932-938. doi:10.1002/eji.202048693

Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? [published online ahead of print, 2020 May 23]. J Microbiol Immunol Infect. 2020;S1684-1182(20)30127-4. doi:10.1016/j.jmii.2020.05.013

Mackey K, King VJ, Gurley S, et al. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020;10.7326/M20-1515. doi:10.7326/M20-1515 [published online ahead of print, 2020 May 15]

Ye Q, Wang B, Mao J. The pathogenesis and treatment of the “Cytokine Storm” in COVID-19. J Infect. 2020;80(6):607-613. doi:10.1016/j.jinf.2020.03.037

Ahsan W, Javed S, Bratty MA, Alhazmi HA, Najmi A. Treatment of SARS-CoV-2: How far have we reached? Drug Discov Ther. 2020;14(2):67‐72. doi:10.5582/ddt.2020.03008

Valk SJ, Piechotta V, Chai KL, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a rapid review. Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No.: CD013600. DOI: 10.1002/14651858.CD013600.

Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924.

INMUNIDAD

Wen W, Su W, Tang H, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31. Published 2020 May 4. doi:10.1038/s41421-020-0168-9

Randolph HE, Barreiro LB. Herd Immunity: Understanding COVID-19. Immunity. 2020;52(5):737‐741. doi:10.1016/j.immuni.2020.04.012

Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med. 2020;217(6):e20200678. doi:10.1084/jem.20200678

Grifoni A, Weiskopf D, Ramirez SI et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell (2020), doi: https://doi.org/10.1016/j.cell.2020.05.015

MORBILIDAD

William Gardner, David States & Nicholas Bagley (2020). The Coronavirus and the Risks to the Elderly in Long-Term Care. Journal of Aging & Social Policy, DOI: 10.1080/08959420.2020.1750543

Andrew M. South, Laurie Tomlinson, Daniel Edmonston, Swapnil Hiremath and Matthew A. Sparks. Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic. Nat Rev Nephrol (2020). https://doi.org/10.1038/s41581-020-0279-4

Zhou F, Yu T, Du R,Fan G, Liu Y, Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 11. pii: S0140-6736(20)30566-3. doi: 10.1016/S0140-6736(20)30566-3. [Epub ahead of print].

Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303‐310. doi:10.1016/j.dsx.2020.04.004 [published online ahead of print, 2020 Apr 9]

GESTACIÓN

Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021 Apr 22. doi: 10.1001/jamapediatrics.2021.1050. Epub ahead of print. PMID: 33885740.

Gavillet M, Rolnik DL, Hoffman MK, Panchaud A, Baud D. Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?. Ultrasound Obstet Gynecol. 2020;55(6):843-844. doi:10.1002/uog.22063.

Kwiatkowski S, Borowski D, Kajdy A, Poon LC, Rokita W, Wielgos M. Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic. Ultrasound Obstet Gynecol. 2020;55(6):841-843. doi:10.1002/uog.22049.

Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G, Liao AH. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020;139:103122. doi:10.1016/j.jri.2020.103122.

Liu H, Liu F, Li J, Zhang T, Wang D, Lan W. Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children. J Infect. 2020 Mar 20. pii: S0163-4453(20)30118-3. doi:10.1016/j.jinf.2020.03.007. [Epub ahead of print]

PACIENTES PEDIÁTRICOS

Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp Pediatr. 2020;10(6):537-540. doi:10.1542/hpeds.2020-0123

Sandhaus H, Crosby D, Sharma A, Gregory SR. Association Between COVID-19 and Kawasaki Disease: Vigilance Required From Otolaryngologists [published online ahead of print, 2020 May 19]. Otolaryngol Head Neck Surg. 2020;194599820930238. doi:10.1177/0194599820930238

Shen KL, Yang YH, Jiang RM, et al. Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement (condensed version of the second edition). World J Pediatr. 2020;16(3):232-239. doi:10.1007/s12519-020-00362-4

Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020 Apr 23;382(17):1663-1665. doi: 10.1056/NEJMc2005073. Epub 2020 Mar 18.

Tagarro A, Epalza C, Santos M, Sanz-Santaeufemia FJ, Otheo E, Moraleda C et al. Screening and Severity of Coronavirus Disease 2019. (COVID-19) in Children in Madrid, Spain. JAMA Pediatr. 2020 Apr 8. doi: 10.1001/jamapediatrics.2020.1346. [Epub ahead of print]

Zhang T, Cui X, Zhao X, Wang J, Zheng J, Zheng G et al. Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia. J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25795. [Epub ahead of print].

Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr Pulmonol. 202. doi: 10.1002/ppul.24718. [Epub ahead of print].

PARÁMETROS DE LABORATORIO

Montrucchio G, Sales G, Rumbolo F, Palmesino F, Fanelli V, Urbino R, et al. Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study. PLoS One. 2021 Feb 8;16(2):e0246771.

García de Guadiana-Romualdo L, Calvo Nieves MD, Rodríguez Mulero MD, Calcerrada Alises I, Hernández Olivo M, Trapiello Fernández W, et al. MR-proADM as marker of endotheliitis predicts COVID-19 severity. Eur J Clin Invest. 2021 Feb 11:e13511.

Gregoriano C, Koch D, Kutz A, Haubitz S, Conen A, Bernasconi L, et al. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study. Clin Chem Lab Med. 2021:cclm-2020-1295.

Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis. 2020;95:304‐307. doi:10.1016/j.ijid.2020.04.061 [published online ahead of print, 2020 Apr 25]

Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T et al. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020 Apr 15;S0012-3692(20)30710-8. doi: 10.1016/j.chest.2020.04.010. Online ahead of print.

Galli C, Plebani M. Clinical laboratory and SARS-CoV-2 infection: where do we stand? Clin Chem Lab Med. 2020 Apr 2. pii: /j/cclm.ahead-of-print/cclm-2020-0372/cclm-2020-0372.xml. doi: 10.1515/cclm-2020-0372. [Epub ahead of print]

Chen X, Yang Y, Huang M, Liu L, Zhang X, Xu J et al. Differences between COVID-19 and suspected then confirmed SARS-CoV-2-negative pneumonia: a retrospective study from a single center. J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25810. [Epub ahead of print]

Henry BM. COVID-19, ECMO, and lymphopenia: a word of caution. Lancet Respir Med. 2020 Mar 13. pii: S2213-2600(20)30119-3.

Ye G, Pan Z, Pan Y, Deng Q, Chen L, Li J et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. 2020 Mar 11. pii: S0163-4453(20)30114-6. doi: 10.1016/j.jinf.2020.03.001. [Epub ahead of print]

Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020 Mar 3. pii: /j/cclm.ahead-of-print/cclm-2020-0198/cclm-2020-0198.xml. doi: 10.1515/cclm-2020-0198. [Epub ahead of print]

AFECTACIONES

CARDIACA

Shi S, Qin M, Shen B, Cai Y, Liu T,Yang F6 et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Mar 25. doi: 10.1001/jamacardio.2020.0950. [Epub ahead of print]

Bansal M. Cardiovascular Disease and COVID-19. Diabetes Metab Syndr. May-Jun 2020;14(3):247-250. doi: 10.1016/j.dsx.2020.03.013. Epub 2020 Mar 25.

HEPÁTICA

Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.

NEUROLÓGICA

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020 Apr 10. doi: 10.1001/jamaneurol.2020.1127. [Epub ahead of print]

RENAL

Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 Mar 20. pii: S0085-2538(20)30255-6. doi: 10.1016/j.kint.2020.03.005. [Epub ahead of print]

IMPACTO PSICOLÓGICO

Jianbo Lai, Simeng Ma, YingWang et al. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Network Open. 2020;3(3):e203976. doi:10.1001/jamanetworkopen.2020.3976

Cuiyan Wang, Riyu Pan, XiaoyangWan et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int. J. Environ. Res. Public Health 2020, 17, 1729; doi:10.3390/ijerph17051729.

Dewey C, Hingle S, Goelz E, Linzer M. Supporting Clinicians During the COVID-19 Pandemic. Ann Intern Med. 2020 Mar 20. doi: 10.7326/M20-1033. [Epub ahead of print]

ONCOLOGÍA

Al-Shamsi HO, Alhazzani W, Alhuraiji A, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020;25(6):e936-e945. doi:10.1634/theoncologist.2020-0213

Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X. Clinical characteristics and outcomes of cancer patients with COVID-19 [published online ahead of print, 2020 May 5]. J Med Virol. 2020;10.1002/jmv.25972. doi:10.1002/jmv.25972.

Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. COVID-19 and Cancer: a Comprehensive Review. Curr Oncol Rep. 2020;22(5):53. Published 2020 May 8. doi:10.1007/s11912-020-00934-7

Dai M, Liu D, Liu M, et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020;10(6):783-791. doi:10.1158/2159-8290.CD-20-0422.

POLÍTICA SANITARIA

Han E, Jin Tan M, Turk E, Sridhar D, Leung GM, Shibuya K et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. The Lancet. Health Policy. Published: September 24, 2020 DOI:https://doi.org/10.1016/S0140-6736(20)32007-9.